Nov 11 (Reuters)- Fuji Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Sep 30, 2025 Sep 30, 2024 Sep 30, 2026 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 51.68 46.14 57.49 29.03 (+12.0 pct) (+12.8 pct) (+11.2 pct) (+20.5 pct) Operating 4.99 3.88 5.52 2.79 (+28.6 pct) (+0.6 pct) (+10.6 pct) (+21.0 pct) Recurring 4.46 4.45 5.24 2.66 (+0.3 pct) (-1.6 pct) (+17.5 pct) (+20.4 pct) Net Net 3.00 6.15 3.81 1.93 (-51.2 pct) (+78.9 pct) (+27.0 pct) (+49.9 pct) EPS 122.94 yen 252.85 yen 155.79 yen 78.92 yen Ann Div 45.50 yen 42.50 yen 47.00 yen -Q2 Div 20.00 yen 20.00 yen 21.00 yen -Q4 Div 25.50 yen 22.50 yen 26.00 yen NOTE - Fuji Pharmaceutical Co Ltd. *Second Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T